异常子宫出血中的血管生成:叙述性综述
本文系统检索截至2021年9月的文献,共纳入35篇研究,探讨血管生成与血管成熟在异常子宫出血(AUB)中的作用。结果提示子宫内膜性AUB(AUB-E)与医源性AUB(AUB-I)均可能与子宫内膜血管生成异常及血管成熟受损相关,但两者机制可能不同。
要点
- AUB-E患者子宫内膜血管内皮生长因子A及其受体1、2,以及血管生成素-1与血管生成素-2比值和Tie-1显著升高。
- AUB-E与对照的子宫内膜微血管密度总体相当。
- AUB-I患者微血管密度及促血管生成因子表达高于对照,短期激素暴露后尤为明显,长期暴露后该效应逐渐消失。
核心结论
- AUB-E和AUB-I很可能与子宫内膜血管生成异常及血管成熟受损相关。
- 本综述支持现有证据,即促血管生成因子增加与抗血管生成因子减少导致血管成熟受损,使血管更脆弱、通透性更高。
- 这一结果与作者假设相符,这些机制似乎在AUB-E和AUB-I的病理生理中起重要作用。
- 探索这些患者的血管生成改变可能为AUB提供治疗靶点。
研究设计与样本
- 叙述性综述,系统文献检索截至2021年9月,检索Cochrane Library Databases、Embase、PubMed和Web of Science。
- 检索词包括angiogenesis与abnormal uterine bleeding等。
- 纳入报告绝经前AUB-E或AUB-I妇女子宫内膜血管生成的研究,排除病例报告、通讯、综述、社论及国际妇产科联盟分类为肌层、肿瘤或感染原因的AUB研究。
- 2158篇文章中纳入35篇,采用Cochrane工具和Newcastle-Ottawa量表进行偏倚风险质量评估。
主要发现
- AUB-E患者血管内皮生长因子A及其受体1和2、血管生成素-1与血管生成素-2比值及Tie-1显著升高。
- 多项研究报告AUB-E患者其他促血管生成与抗血管生成因子差异表达,提示血管成熟异常和血管完整性受损。
- AUB-E患者与对照的子宫内膜微血管密度总体相当。
- AUB-I患者微血管密度及促血管生成因子表达高于对照,尤其短期激素暴露后;长期暴露后该效应逐渐消失,而血管成熟改变在短期和长期暴露后均可见。
临床怎么用
- 作者认为探索这些患者的血管生成改变可能为AUB提供治疗靶点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Abnormal uterine bleeding (AUB) has a significant socioeconomic impact since it considerably impacts quality of life. Therapeutic options are frequently based on trial and error and do not target disease aetiology. Pathophysiological insight in this disease is required for the development of novel treatment options. If no underlying cause is found for the AUB (e.g. fibroids, adenomyosis, polyps), endometrial-AUB (AUB-E) is usually caused by a primary endometrium disorder. When AUB is induced by prescribed (exogenous) hormones, it is classified as iatrogenic-AUB (AUB-I). Considering vascular modulation and function, AUB-E and AUB-I both could potentially result from abnormal vascularization in the endometrium due to alterations in the process of angiogenesis and vascular maturation. OBJECTIVE AND RATIONALE: We aim to investigate the fundamental role of angiogenesis and vascular maturation in patients with AUB and hypothesize that aberrant endometrial angiogenesis has an important role in the aetiology of both AUB-E and AUB-I, possibly through different mechanisms. SEARCH METHODS: A systematic literature search was performed until September 2021 in the Cochrane Library Databases, Embase, PubMed, and Web of Science, with search terms such as angiogenesis and abnormal uterine bleeding. Included studies reported on angiogenesis in the endometrium of premenopausal women with AUB-E or AUB-I. Case reports, letters, reviews, editorial articles, and studies on AUB with causes classified by the International Federation of Gynecology and Obstetrics as myometrial, oncological, or infectious, were excluded. Study quality was assessed by risk of bias, using the Cochrane tool and the Newcastle-Ottawa Scale. OUTCOMES: Thirty-five out of 2158 articles were included. In patients with AUB-E, vascular endothelial growth factor A and its receptors (1 and 2), as well as the angiopoietin-1:angiopoietin-2 ratio and Tie-1, were significantly increased. Several studies reported on the differential expression of other pro- and antiangiogenic factors in patients with AUB-E, suggesting aberrant vascular maturation and impaired vessel integrity. Overall, endometrial microvessel density (MVD) was comparable in patients with AUB-E and controls. Interestingly, patients with AUB-I showed a higher MVD and higher expression of proangiogenic factors when compared to controls, in particular after short-term hormone exposure. This effect was gradually lost after longer-term exposure, while alterations in vessel maturation were observed after both short- and long-term exposures. WIDER IMPLICATIONS: AUB-E and AUB-I are most likely associated with aberrant endometrial angiogenesis and impaired vessel maturation. This review supports existing evidence that increased proangiogenic and decreased antiangiogenic factors cause impaired vessel maturation, resulting in more fragile and permeable vessels. This matches our hypothesis and these mechanisms appear to play an important role in the pathophysiology of AUB-E and AUB-I. Exploring the alterations in angiogenesis in these patients could provide treatment targets for AUB.
引用
- Middelkoop MA, Don EE, Hehenkamp WJK, et al. Angiogenesis in abnormal uterine bleeding: a narrative review. Hum Reprod Update. 2023. PMID: 36857162. doi:10.1093/humupd/dmad004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。